|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 22.96 USD | -2.30% |
|
-0.99% | -50.41% |
| 10-19 | Collegium Pharmaceutical Settles Nucynta Patent Litigation for $17 Million | MT |
| 10-09 | Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Other Pharmaceuticals | -2.30% | -0.99% | -50.41% | -35.40% | +9.02% | 747M |  |  | |
- Stock Market
- Stocks
- COLL Stock
- Charts Collegium Pharmaceutical, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
